Arrowhead Pharmaceuticals
ARWR
#2098
Rank
โ‚น803.26 B
Marketcap
โ‚น5,810
Share price
-0.64%
Change (1 day)
196.79%
Change (1 year)

Revenue for Arrowhead Pharmaceuticals (ARWR)

Revenue in 2025 (TTM): โ‚น48.97 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น51.48 Billion. In 2024 the company made a revenue of โ‚น0.21 Billion a decrease over the revenue in the year 2023 that were of โ‚น15.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น48.97 B22737.5%
2024 โ‚น0.21 B-98.58%
2023 โ‚น15.12 B-34.31%
2022 โ‚น23.03 B114.26%
2021 โ‚น10.74 B84.1%
2020 โ‚น5.83 B-49.95%
2019 โ‚น11.66 B252.8%
2018 โ‚น3.30 B69.51%
2017 โ‚น1.95 B540.77%
2016 โ‚น0.30 B1696.54%
2015 โ‚น16.94 M-11.46%
2014 โ‚น19.14 M77.04%
2013 โ‚น10.81 M-29.96%
2012 โ‚น15.43 M1118%
2011 โ‚น1.26 M-99.37%
2010 โ‚น0.20 B34.05%
2009 โ‚น0.14 B93.39%
2008 โ‚น77.24 M
2006 โ‚น15.68 M-51.17%
2005 โ‚น32.11 M
2002 โ‚น0.11 M-54.84%
2001 โ‚น0.26 M-77.46%
2000 โ‚น1.16 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Alnylam Pharmaceuticals
ALNY
โ‚น288.43 B 460.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น17.32 B-66.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น22.57 B-56.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
โ‚น16.38 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.279 T 15,982.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
โ‚น197.85 B 284.31%๐Ÿ‡บ๐Ÿ‡ธ USA